NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/21/2024
Back to search
Official data from USPTO
K KURE IT CANCER RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
03/21/2024
Trademark type
Combined
Nice classes
36
Filing date
02/28/2013
Registration date
10/22/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/21/2024
Last transaction
03/21/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
07/01/2010
First use in commerce
07/01/2010
Drawing code
3
Owner type
03
Owner location
Newport Beach, CA
Examiner
MCCAULEY, BRENDAN
Law office
M50
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of a partially filled square with rounded corners forming a negative image of the letter "K" and a horizontal line with a circle intersecting the line in the center extending from the "K" with the remaining literal element of the mark "Kure it cancer research" positioned to the right of the square with "Kure it" on one line and "cancer research" positioned below; and the letter "K" in uppercase and the remaining letters in lowercase.
Holders and representatives
Holders
KURE IT!, INC.
Representatives
Rob G. Leach CHARMASSON, BUCHACA & LEACH, LLP
Technical classification
Nice Classes
Class 36
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Charitable foundation servicesproviding fundraising activitiesfundingscholarships and/or financial assistance for cancer research; Charitable fundraising services; Charitable fundraising services by means of organizing and conducting special events; Charitable fundraising services for promoting researcheducation and other activities relating to cancer
Publications
History of USPTO decisions and trademark events.
29 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/21/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/21/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/21/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
10/20/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/22/2022
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/14/2020
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/14/2020
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
01/03/2020
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
11/25/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/25/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/22/2019
E815
TEAS SECTION 8 & 15 RECEIVED
10/22/2019
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/22/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
10/22/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/06/2013
PUBO
PUBLISHED FOR OPPOSITION
08/06/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/17/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/01/2013
ALIE
ASSIGNED TO LIE
06/28/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/12/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
06/12/2013
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/12/2013
GNEA
EXAMINERS AMENDMENT E-MAILED
06/12/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/12/2013
DOCK
ASSIGNED TO EXAMINER
06/11/2013
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/07/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/06/2013
NWAP
NEW APPLICATION ENTERED
03/04/2013
Continuous trademark protection
Get notified about every new filing that threatens K KURE IT CANCER RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.